Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dynamic42
Jena, Thuringia, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Dynamic42 develops human organ-on-chip models (e.g., liver, intestine, alveolus, tumor) tested for advanced preclinical research, including demonstration of preclinical efficacy of vorinostat against pancreatic ductal adenocarcinoma in 3D tumor-on-chip models.
- Therapeutic areas
- GastroenterologyOncologyInfectious DiseasesPulmonology
- Modalities
- DeviceMicrophysiological systemNanoparticle
- Industry
- Non-Drug Biotech
02
Partnerships
Heinrich Heine University DüsseldorfJena University HospitalOhio Lumex (exclusive distributor in US and Canada)
Beyond the preview
Go deeper on Dynamic42.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dynamic42.